ID   BVD2-21C11.3
AC   CVCL_9166
SY   BVD2-21C11
DR   CLO; CLO_0002054
DR   ATCC; HB-9569
DR   Wikidata; Q54798674
RX   Patent=US5070013;
RX   PubMed=1387110;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9569.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04141; Human CSF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 10
//
RX   Patent=US5070013;
RA   Abrams J.S., Van Dyke R.E.;
RT   "Immunochemical assay for human granulocyte-macrophage colony
RT   stimulating factor.";
RL   Patent number US5070013, 03-Dec-1991.
//
RX   PubMed=1387110; DOI=10.1111/j.1600-065x.1992.tb01406.x;
RA   Abrams J.S., Roncarolo M.-G., Yssel H., Andersson U., Gleich G.J.,
RA   Silver J.E.;
RT   "Strategies of anti-cytokine monoclonal antibody development:
RT   immunoassay of IL-10 and IL-5 in clinical samples.";
RL   Immunol. Rev. 127:5-24(1992).
//